Catégorie > 03forum-arret-des-hemorragies

YPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd"> Adjuvant therapies for management of hemorrhagic shock: a narrative review Daniel Y et Al. Crit Care. 2025 Mar 29;29(1):138 Background Severe bleeding remains a leading cause of death in patients with major trauma, despite improvements in care during the acute phase, especially the application of damage control concepts. Death from hemorrhage occurs rapidly after the initial trauma, in most cases before the patient has had a chance to reach a hospital. Thus, the...

Efficacy and safety of novel freeze-dried plasma products in a porcine combat casualty model Dufour-Gaume F et Al. Transfusion. 2024 Sep;64(9):1670-1682 ----------- Le Plyo est un des produits phares développé par le CTSA. Les recherches continuent pour  améliorer les caractérisques. C'est le sens de ce tavail qui porte sur du Plyo plus concentré ou enrichi en lyophylisat de...

Dried Plasma for Major Trauma: Past, Present, and Future Peng HT et Al. Life   2024 ,  14 (5), 619; https://doi.org/10.3390/life14050619   ---------------------------- Le...

Barret WJ et Al. J Trauma Acute Care Surg . 2025 Aug 18;99(3):357–363.   Prehospital use of tranexamic acid ( TXA) has grown substantially over the past decade despite...

Tourniquet self-application assessment in cold weather conditions Benítez YC et al. BMC Emergency Medicine (2023) 23:101 ---------------------------- Le chox d'un...